ESR1 and breast carcinoma: The basal level of miR196a in a panel of breast cell lines including the breast epithelial cell line, MCF10A, the estrogen receptor positive MCF7 and T47D, and the triple negative basal-like breast cancer cell lines MDA-MB-231, MDA-MB-468 and MDA-MB-435 was first analyzed.